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Abstract
Background:  As studies of molecular biology system attempt to achieve a comprehensive
understanding of a particular system, Type 1 errors may be a significant problem. However, few
investigators are inclined to accept the increase in Type 2 errors (false positives) that may result
when less stringent statistical cut-off values are used. To address this dilemma, we developed an
analysis strategy that used a stringent statistical analysis to create a list of differentially expressed
genes that served as "bait" to "fish out" other genes with similar patterns of expression.
Results:  Comparing two strains of mice (NOD and C57Bl/6), we identified 93 genes with
statistically significant differences in their patterns of expression. Hierarchical clustering identified
an additional 39 genes with similar patterns of expression differences between the two strains.
Pathway analysis was then employed: 1) identify the central genes and define biological processes
that may be regulated by the genes identified, and 2) identify genes on the lists that could not be
connected to each other in pathways (potential false positives). For networks created by both gene
lists, the most connected (central) genes were interferon gamma (IFN-γ) and tumor necrosis factor
alpha (TNF-α). These two cytokines are relevant to the biological differences between the two
strains of mice. Furthermore, the network created by the list of 39 genes also suggested other
biological differences between the strains.
Conclusion: Taken together, these data demonstrate how stringent statistical analysis, combined
with hierarchical clustering and pathway analysis may offer deeper insight into the biological
processes reflected from a set of expression array data. This approach allows us to 'recapture" false
negative genes that otherwise would have been missed by the statistical analysis.
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Background
The comprehensive analysis of gene microarray datasets,
each containing thousands of genes, face statistical "Catch
22" between Type 1 (false negatives) and Type 2 (false
positive) errors. In traditional "linear paradigm" research,
Type 2 errors can be devastating as they provide false con-
clusions upon which further work and conclusions may
be based. Therefore, investigators often adopt rigorous
statistical criteria to reduce Type 2 errors and like to see
experiments repeated (preferably by other investigators)
before believing a conclusion.
Conclusions based on analysis of microarray often serve
only as the initial foundation for subsequent confirma-
tion and more traditional avenues of research. As a result,
investigators using expression arrays tend to be less con-
cerned about the potential for a small number of false
positives. However, a high number of false negatives may
result from the failure to recognize the involvement of
specific biological processes or molecular networks in the
physiological system under study. As a result investigators
using comprehensive expression arrays often find them-
selves in this "Catch 22" situation. If they use traditional
statistical methods, with conservative multiple test correc-
tions, there is potential for a large number of Type 1
errors. If they use "generous" statistical criteria to reduce
Type 1 errors, they generate a list of genes so large that it
cannot be comprehensively analyzed in a meaningful
way.
Presently, we investigated the use of a novel data mining
strategy. First, a microarray dataset was subjected to anal-
ysis using very stringent statistical criteria to define spleen
leukocyte genes whose expression was different between
the two strains of mice. Second, this set of "core" differen-
tially expressed genes, was then used as "bait" in a cluster
analysis to pull out another set of "peripheral" genes
whose expression patterns was very similar to that of the
core genes, although these "peripheral" genes had not
been identified by the initial statistical criteria. This was
done by subjecting the whole set of expression array data
to hierarchical clustering and then examining the result-
ing "gene tree" for sub-branches that contained a high per-
centage of core genes.
Finally, we conducted network analyses on both lists of
genes as a way to sort out genes that are not biologically
connected to the other genes on the list and to define the
molecular networks that were represented within each list
of genes. This allowed us to compare the physiological
processes represented by the two resulting networks.
Results
We analyzed expression array data from 20 samples of
spleen leukocytes with 10 samples from the NOD and 10
samples from C57BL/6 female mice. Half of the samples
from each strain were collected at two weeks of age and
half at four weeks. First, we conducted a two-way ANOVA
on the 26,530 probesets to determine genes with statisti-
cally significant (p < 0.001) differences between strains
and age groups. The stringent Bonferroni multiple correc-
tion test was used to reduce the number of false positives.
With the Bonferroni correction, we performed one test for
each probeset and then ranked the 26,530 p-values. For
99.9% confidence we divide 0.001 by 26530 to get 3.77 ×
10-8. If any p = value is lower than 3.77 × 10-8 it passes the
Bonferroni multiple correction test. Thus, use of Bonfer-
roni for mitigating false error rates in data sets with large
numbers of tests resulted in highly conservative p-values
and a very small number of false positives. This analysis
found 93 probesets with statistically significant differ-
ences between strains. Because genes expressed differently
at the two ages, but not between the two strains, likely rep-
resent normal developmental process, we focused on the
93 probesets that varied between the strains. The 93
probesets can be divided into two groups. One group is
the 14 probesets with relatively high expression in NOD
and low expression in C57BL/6 mice. The second group
contains the 79 probesets with relatively low expression in
NOD and high expression in C57BL/6 mice.
Hierarchical clustering
Although our use of the Bonferroni correction reduces the
number of false positives on our gene lists, it increases the
occurrence of Type 1 errors (false negatives). To capture
genes whose expression followed the same pattern seen
for the lists of 14 and 79 probesets described above, we
conducted hierarchical clustering on 26530 probesets and
organized them into a "gene-tree". Using the 14 probesets
with relatively high expression in NOD to guide us
towards sub-branches within the gene-tree, we found an
extra 11 probesets that had a similar expression pattern.
The combined total of 25 probesets (14 plus 11) were
themselves organized using the Gene Tree feature in
GeneSpring program (Figure 1). The 14 probesets with
significant differences between strains differences (P <
0.001), are marked by black bars. Statistical analysis of the
11 genes (without multiple test correction) indicated
strain differences with a p-value of 0.00022 or less. This
result demonstrates that all 25 probesets clearly have
higher levels of expression in NOD than C57BL/6 mice.
By the same approach, we found an extra 28 probesets
with the same expression pattern as the 79 probesets with
lower expression in NOD than C57BL/6 mice (data not
shown). In total, the hierarchical cluster analysis yielded
an additional 39 probesets that show expression differ-
ences between the two strains.BMC Genomics 2008, 9(Suppl 2):S12 http://www.biomedcentral.com/1471-2164/9/S2/S12
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Molecular networks
The list of 93 probesets was uploaded to the Ingenuity
server which contains information about millions of
known connections between individual genes. Our list of
93 probesets represented 46 different focus genes listed in
the Ingenuity Pathway Knowledge Base (IPKB) The
remaining probesets represented genes about which the
IPKB did not contain information and could not connect
to other genes.
The database created three major networks. We merged
those 3 networks and created a single network (Figure
2A). In Figure 2A, there are 38 focus genes (derived from
the 93 probesets) and 67 non-focus genes indicated by
gray and white icons, respectively. The number of connec-
tions of the nine most connected genes (central genes) is
presented in Table 1 IFN-γ and TNFα had the greatest
number of connections (35 and 32, respectively).
The list of 39 additional probesets obtained by hierarchi-
cal clustering analysis also was subjected to Ingenuity
Pathways Analysis (IPA). The 39 probesets represented 24
genes found in IPKB. IPA created two major networks.
The merged network from those two is presented in Figure
2B, and it contain 21 focus genes and 51 non-focus genes.
Table 1 also shows the number of connections of the nine
most connected genes (central genes) in the network from
Figure 2B. The largest numbers of connections again
involved IFN-γ (24) and TNF-α (26).
Discussion
In the NOD animal model of autoimmune (Type 1) dia-
betes, the first sign of pathology is seen at about 5-weeks
of age [1,2]. As the animals get older, the infiltration of the
pancreas with leukocytes, and the subsequent destruction
of insulin producing β-cells, gets progressively worse until
the mice become diabetic. To gain further insight into
mechanisms and pathways involved, our study focused
on the molecular abnormalities at 2–4 weeks of age [3,4].
We used comprehensive molecular characterization
(molecular phenotyping) at both the transcriptome and
proteome levels [3,5,6].
In order to gain insight from such large datasets, it is
important to develop an effective strategy for data mining
and analysis. The problems associated with analyzing
expression data from a very large number of genes (dis-
cussed previously) have lead to development of alterna-
tive statistically approaches and tools. Cluster analysis
and principal component analysis have become popular
tools for the analysis of expression array data [7-12].
When combined with further downstream data process-
ing and/or data mining, these can be effective tools to gain
more insight from a large dataset. However, many investi-
gators are uncomfortable with the use of these clustering
methods to define sets of genes that are differentially
expressed when comparing different groups of biological
samples. They want to know that the difference is statisti-
cally significant, i.e. has not just simply appeared by
chance. To take advantage of the strengths and compen-
sate for the weaknesses of each of these data analysis
approaches, we have combined them. First, we used a tra-
ditional statistical analysis (ANOVA) with very stringent
criteria and a multiple test correction to define a set of 93
genes that showed highly significant differences in expres-
sion levels between the two strains of mice. We also con-
Hierarchical cluster of 25 probesets with relatively high  expression in NOD and low expression in C57BL/6 mice Figure 1
Hierarchical cluster of 25 probesets with relatively high 
expression in NOD and low expression in C57BL/6 mice. 
The 14 probesets with significant differences between the 
strains (P < 0.001) are marked by black bars on the right side 
of the figure. The intensity of the node color indicates the 
degree of increase (red) or decrease (blue) of the gene 
expression signal relative to the mean signal intensity.
C57 NOD NOD
Table 1: Central genes in networks from figure 2 and their 
number of connection within the network.
93 Probesets Merged Network 39 Probesets Merged Network
Gene # of Connection Gene # of Connection
IFNG 35 TNF 26
TNF 32 IFNG 24
TGFB1 30 TP53 23
FOS 19 IL1B 21
IL4 18 IL6 16
CTNNB1 13 CDKN1A 14
NFYB 12 IL15 13
E2F1 12 F2 13
BMP2 8 EGF 13BMC Genomics 2008, 9(Suppl 2):S12 http://www.biomedcentral.com/1471-2164/9/S2/S12
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Network analysis by Ingenuity Pathway Analysis Figure 2
Network analysis by Ingenuity Pathway Analysis. A: Merged network created from the 93 probesets that have highly significant 
strain differences by 2-way ANOVA. The network contains 38 focus genes (i.e., genes originating from the list of 93 probesets) 
indicated by gray icons. B: Merged network created by the 39 additional probesets from the hierarchical analysis.
A.
B.BMC Genomics 2008, 9(Suppl 2):S12 http://www.biomedcentral.com/1471-2164/9/S2/S12
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ducted a hierarchical clustering analysis of the gene
expression dataset. Then, we examined the resulting gene
tree to find genes with expression patterns very similar to
(i.e., clustering together with) the 93 genes. This process
defined another 39 genes where the differences between
the expression levels of the two strains did not reach the
stringent criteria of statistical significance.
We have found that the best way to gain insights from
such an analysis is to evaluate the biological "relatedness"
of the genes by conducting a pathway analysis. The Inge-
nuity data-mining tool uses knowledge from the literature
to evaluate how best to connect all the genes on a list
(focus genes) to each other with the help of some non-
focus genes. This approach does have a bias toward genes
for which there is a lot of published data, and is not likely
to connect a gene for which little more than its name is
known. However, for the purpose of gaining a broad
understanding of the underlying biological phenomena
these newly defined genes cannot be used. They must be
mined individually by different, and much more time-
consuming, approaches. Another advantage of using the
pathway analysis to mine large gene lists is that it may
help sort out false positives. Any false positive gene on a
list is not likely to be connected to the other genes because
it would not likely be part of the underlying biological
processes. Therefore, that gene is also less likely to become
a part of the network created by the Ingenuity server.
When we conducted pathway analysis on the list of 93
probesets that showed highly significant differences
between the two strains of mice, we created a network in
which IFN-γ and TNF-α were the most central (i.e., had
the most connections to other genes in the network). The
third highly connected gene in that network, TGF-β1, is a
multifunctional growth factor involved in many different
immunological processes [13,14]. Both IFN-γ and TNF-α
are important for the process of reducing autoimmunity
in the developing immune system [15-17]. Furthermore,
when combined with IL1-β these cytokines are known to
be directly cytotoxic to insulin producing beta-cells. This
has been hypothesized to be an important mechanism of
autoimmune diabetes [18-20].
When we evaluated the network created by the 39 genes
identified only by cluster analysis, we again found that
TNF-α and INF-γ have the most connections to other
genes in the network. This confirmed that genes on the
two lists were highly connected to each other not just by
expression patterns, but also by the underlying physiol-
ogy. Yet some of the other central genes in the network
created from the list of 39 genes were different and may
help to further define and interpret the network created
from the list of 93 genes. First, we should consider IL1-β,
which, as mentioned above, is cytoxic to β-cells. Second,
one of the many roles of TGF-β1 is that it is an anti-
inflammatory cytokine [21]. The network from the list of
39 genes contains three pro-inflammatory cytokines
(IL1β, IL6, and IL15) among its most central genes. This
would suggest that not only regulation of development of
autoimmune T-lymphocytes, but also regulation of
inflammatory responses may define the critical differ-
ences in the immune system of young mice that will, or
will not, develop autoimmune diabetes at a later age. This
suggests that a more detailed study of the interaction of
regulatory processes for inflammation and autoreactive T-
lymphocytes is merited.
Conclusion
This paper demonstrates how stringent statistical analysis
can be combined with hierarchical clustering to gain
much better insight from a set of expression array data.
The combination identifies critical false negative genes
missed by the statistical analysis, such that conclusions
and models based on statistical data can be refined and
expanded.
Methods
Collection of tissues and gene expression analysis
The specific methods for the collection of spleen leuko-
cytes and analysis of gene expression on Affymetrix
expression arrays have been described elsewhere [4]. This
paper also describe the process of filtering through the
44,000 probesets present in the MOE 403A and MOE
403B expression arrays to identify the 26,530 probesets
that are expressed at least once in the spleen leukocyte
samples. This list of 26,530 probesets was subjected to sta-
tistical and cluster analysis.
Statistical and cluster analysis
The expression data produced by the MAS 5.0 software
was imported into GeneSpring software (version 7.3.1,
Silicon Genetics, Redwood, CA) and analyzed. The dataset
consists of a total of 20 samples that can be divided into
four groups if both strain (NOD and C57BL/6) and age (2
week and 4 week) are considered. We conducted a two-
way ANOVA test (P < 0.001) with Bonferroni multiple test
corrections to produce lists of differentially expressed
genes with significant differences between strains and age
groups. We also conducted hierarchical clustering with
Pearson's Correlation Coefficient on all 26,530 probesets.
The list of 26,530 probesets was organized into a "gene-
tree" where genes were grouped according to similarities
in their expression patterns across all 20 samples. We used
the genes from the two-way ANOVA to guide us towards
sub-branches that contained clusters of genes with either
high or low expression in NOD mice. We collected all
genes from each sub-branch to create a new list of genes
that followed the same expression pattern as the genesBMC Genomics 2008, 9(Suppl 2):S12 http://www.biomedcentral.com/1471-2164/9/S2/S12
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with statistically significant differences in expression
between the strains.
Analysis of molecular networks using Ingenuity
The gene lists were analyzed through the use of Pathways
Analysis (Ingenuity Systems, http://www.ingenuity.com)
as previously described [4]. The list of genes containing
gene identifiers (i.e. Affymetrix ID of probesets) was
uploaded into the application. Each gene identifier was
mapped to its corresponding gene object in the Ingenuity
Pathways Knowledge Base. Networks of these genes were
then algorithmically generated based on their connectiv-
ity. We used IPA to visualize and explore molecular net-
works created from the lists of probesets. The networks
created from a list consist of genes from that list (called
focus genes) and genes that are not on the list but help
connect all the genes together in a network (called non-
focus genes). In Figure 2, the focus and non-focus genes
are depicted with gray and white icons, respectively. Due
to the server's restriction that no network can contain
more than 35 genes, both gene lists were used to create
multiple networks. This division into multiple networks is
usually just an artifact, and the database often contains
information demonstrating that there are multiple con-
nections between genes from different networks. The IPA
allows the easy merging of individual networks. We used
the "merge networks" feature to create a single network.
We then counted the connections for the central genes
which had connections to at least eight genes in the
merged network.
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